Search

everythinglearnresearchcommunity

for

Search:↓

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

The treatments stopped hair regrowth in mice.

Enhancing immune response can improve cancer treatment effectiveness.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Stem cell therapy can help reduce hair loss from COVID-19 vaccination.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

ILC1-like cells can cause alopecia areata by themselves.

CD34 is crucial for skin tumor development in mice.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

The method effectively delivers vaccines through the skin without needles.

The assay effectively identifies compounds that affect immune cell activation.

A new patch can deliver stable antibodies over time for potential HIV treatment.

The Fas/FasL pathway may play a role in alopecia areata.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

UC.145 may be a new biomarker for predicting gastric cancer.